# Effect of Anagrelide Hydrochloride on Any Changes in Heart Function in Healthy Volunteers

> **NCT01552928** · PHASE1 · COMPLETED · sponsor: **Shire** · enrollment: 60 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Anagrelide 0.5 mg
- **DRUG:** Anagrelide 2.5 mg
- **DRUG:** Moxifloxacin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01552928
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03-29
- **Primary completion:** 2012-07-25
- **Final completion:** 2012-07-25
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2021-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01552928

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01552928, "Effect of Anagrelide Hydrochloride on Any Changes in Heart Function in Healthy Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01552928. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*